GIST News A Wave of Information By the LIFE RAFT GROUP

Make a difference - Donate Today

  • Print
  • Email

April 2008

Jump to section:

  • The doctor is in: common patient questions answered by Jonathan Trent, M.D.
  • Concerns raised, FDA meets on ESAs by Elizabeth Braun Erythropoetin stimulating agents (ESAs) promote the production of red blood cells by red blood stem cells. They are commonly utilized to reduce the frequency of transfusions in cancer patients. In recent months, significant concerns have been raised about ESAs, questioning whether or not the risks outweigh the benefits.
  • Gerald & Deanne got 45 happy years Gerald Eugene Snodgrass passed away peacefully at his Renton, WA home on Thursday, Nov. 15, 2007 at the age of 70.
  • Call dissects 2007 LRG study by Jerry Call In last month’s newsletter, the Life Raft Group published its study on the effects of imatinib dose upon the survival of metastatic GIST patients. On February 4, we also held a webcast, “The Link Between Dosage and Survival”. Since then we have had a number of questions about the study.

     

  • More than a survivor by Rob Anthes  Lawrence High School senior Chandell Fuqua widened his brown eyes and inhaled a deep, calming breath.
  • April 2008 US clinical trials update by Jim Hughes